CLEVELAND — Researchers narrowed down what appears to be the correct dosage during a first ever rigorous clinical trial examining LSD as a treatment for generalized anxiety disorder, with results ...
Healio: Antidepressants may improve treatment response in generalized anxiety disorder vs. placebo
Please provide your email address to receive an email when new articles are posted on . Treatment of generalized anxiety disorder with an antidepressant increased the treatment response rate by 41%.
Science Daily: AI may help clinicians personalize treatment for generalized anxiety disorder
Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial ...
Cognitive behavioral therapy (CBT) should be considered first-line treatment for generalized anxiety disorder in adults, according to a systematic review and network meta-analysis of 66 randomized ...
DaylightRx is a 90-day treatment. The Food and Drug Administration (FDA) has cleared DaylightRx, a prescription digital therapeutic for the treatment of generalized anxiety disorder (GAD). DaylightRx ...
Business Wire: Sunovion and Otsuka Initiate Clinical Development of Ulotaront for the Treatment of Generalized Anxiety Disorder
Sunovion and Otsuka Initiate Clinical Development of Ulotaront for the Treatment of Generalized Anxiety Disorder
Credit: Getty Images. Lexapro is a selective serotonin reuptake inhibitor. The Food and Drug Administration (FDA) has approved Lexapro (escitalopram) for the treatment of generalized anxiety disorder ...
WKYC3: First clinical trial discovers LSD dose that may help treat generalized anxiety disorder
First clinical trial discovers LSD dose that may help treat generalized anxiety disorder
Monthly Prescribing Reference: LSD Drug Candidate Gets Breakthrough Tx Status for Generalized Anxiety Disorder